Figure S2 from Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer
Year: 2023
Type: other
Abstract: Supplemental Figure 2. Orthogonal assays for cell viability in drug resistant models.
Authors: Elena Ivanova, Mari Kuraguchi, Man Xu, Andrew J. Portell, Luke Taus, Irmina Diala, Alshad S. Lalani, Jihyun Choi, Emily S. Chambers, Shuai Li, Shengwu Liu, Ting Chen, Thanh U. Barbie, Geoffrey R. Oxnard, Jacob J. Haworth, Kwok-Kin Wong, Suzanne E. Dahlberg, Amir A. Aref, David A. Barbie, Magda Bahcall, Cloud P. Paweletz, Pasi A. Jänne
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361934848